NRB Bearings. Strong Show BUY RESULTS REVIEW 4QFY18 23 MAY Highlights of the quarter

Similar documents
BLS International Services

Healty cigarette-driven growth

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter

Crompton Greaves Consumer Electricals

Crompton Greaves Consumer Electricals

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter

Intellect Design Arena

Multi Commodity Exchange

JBM Auto. Ready to take off BUY RESULTS REVIEW 1QFY19 07 AUG Key highlights

Maruti Suzuki. A Trough Quarter BUY RESULTS REVIEW 3QFY19 25 JAN CMP(as on 25 Jan 2019) Rs 6,516 Target Price Rs 7,400

Near-term pressure, but long-term outlook positive

Neuland Labs BUY RESULTS REVIEW 1QFY19 12 AUG 2018

Subros BUY RESULTS REVIEW 2QFY19 30 OCT CMP (as on 29 Oct 2018) Rs 268 TP Rs 435. Key highlights

J. Kumar Infraprojects

Exide Industries BUY RESULTS REVIEW 4QFY18 08 MAY Highlights of the quarter. CMP (as on 08 May 2018) Rs 268 Target Price Rs 298

Navin Fluorine International

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Discounting $45/bbl of realisation

Central Depository Services

Central Depository Services

Ahluwalia Contracts. Cautious optimism BUY RESULTS REVIEW 4QFY17 31 MAY Highlights of the quarter

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Gulf Oil Lubricants BUY RESULTS REVIEW 1QFY19 09 AUG Key highlights

Alkem Labs BUY RESULTS REVIEW 1QFY19 11 AUG story remains on-track. Maintain BUY with a revised TP of Rs 2,410 (24x FY20E EPS).

Bajaj Auto BUY RESULTS REVIEW 1QFY18 21 JUL Highlights of the quarter

Torrent Pharma BUY RESULTS REVIEW 1QFY18 01 AUG 2017

Suprajit Engineering. Synergies to accrue BUY COMPANY UPDATE 16 SEP 2016

Central Depository Services

Sun Pharma BUY RESULTS REVIEW 1QFY19 16 AUG 2018

PI Industries BUY RESULTS REVIEW 1QFY19 07 AUG Highlights of the quarter

Vinati Organics BUY RESULTS REVIEW 2QFY19 29 OCT INDUSTRY CHEMICALS CMP (as on 29 Oct 2018) Rs 1,408 Target Price Rs 1,700

Capital Goods. 3QFY18E Results Preview. 10 Jan Sujit Jain

Agrochemicals. 3QFY18E Results Preview 09 JAN Basanth Patil

Hindustan Unilever BUY RESULTS REVIEW 4QFY17 18 MAY 2017

Carborundum Universal

Hindustan Petroleum Corporation

Alkem Labs BUY RESULTS REVIEW 3QFY19 09 FEB CMP (as on 08 Feb 2019) Rs 1,904 Target Price Rs 2,340. Highlights of the quarter

Kalpataru Power Transmission

Geared for version 3.0

Mahanagar Gas BUY RESULTS REVIEW 1QFY19 01 AUG Highlights of the quarter. CMP (as on 1 Aug 2018) Rs 947 Target Price Rs 1,292

Hero MotoCorp BUY RESULTS REVIEW 2QFY19 16 OCT CMP (as on 16 Oct 2018) Rs 2,898 Target Price Rs 3,602. Highlights of the quarter

Jubilant Life Sciences

Ambuja Cement. Realisations-driven beat SELL RESULTS REVIEW 2QCY17 25 JUL Highlights of the quarter

Strong volumes, offset by costs

Dishman Carbogen Amcis

Bajaj Auto NEUTRAL RESULTS REVIEW 2QFY16 23 OCT Key highlights. CMP (as on 23 Oct 2015) Rs 2,514 Target Price Rs 2,720

Growth + cash flows = BUY

Real Estate. 3QFY19E Results Preview. 11 Jan Parikshit D Kandpal, CFA

Dr. Reddy s Labs. Misery continues SELL RESULTS REVIEW 1QFY18 28 JUL 2017

Bharat Forge. Cyclical headwinds persist but structural story intact BUY COMPANY UPDATE 9 DEC Key takeaways

Hindustan Petroleum Corporation

Agriculture. 4QFY18E Results Preview 13 APR Madhukar Ladha

J. Kumar Infraprojects

Music Broadcast. In-line but muted BUY RESULTS REVIEW 2QFY19 26 OCT Key highlights. CMP (as on 26 Oct 2018) Rs 328 Target Price Rs 387

Cyient. Good show, priced in NEUTRAL RESULTS REVIEW 4QFY17 21 APRIL Highlights of the quarter

Crompton Greaves Consumer Electricals

ICICI Prudential Life

Navin Fluorine International

Dilip Buildcon. Strong comeback BUY RESULT REVIEW 1QFY19 16 AUG Highlights of the quarter. CMP (as on 16 Aug 2018) Rs 847 Target Price Rs 1,434

Tata Steel. JV comes to fruition BUY COMPANY UPDATE 21 SEP Other key highlights. CMP (as on 20 Sep 17) Rs 688 Target Price Rs 818

Bharti Infratel BUY RESULT REVIEW 3QFY19 25 JAN 2019

Sonata Software. On growth path BUY RESULTS REVIEW 1QFY18 16 AUG Highlights of the quarter

Coromandel International

Pre-sales pickup key trigger

Weak numbers in peak quarter

Max Financial. Improving margins! BUY RESULTS REVIEW 4QFY18 30 MAY Highlights of the quarter

PSP Projects. Marginal miss BUY RESULTS REVIEW 1QFY19 10 AUG 2018

Bharat Petroleum Corporation

Mphasis. Growth drivers intact BUY RESULTS REVIEW 3QFY19 25 JAN 2019

Brigade Enterprises. Stable performance BUY RESULTS REVIEW 2QFY19 14 NOV 2018

ITC BUY RESULTS REVIEW 1QFY19 27 JUL 2018

Multi Commodity Exchange

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

NIIT Technologies. NEUTRAL Higher capex weighing on FCF RESULTS REVIEW 2QFY15 16 OCT 2014

Ambuja Cement. Weak numbers SELL RESULTS REVIEW 1QCY17 01 MAY 2017

Construction. 4QFY18E Results Preview 14 APR Parikshit D Kandpal

Insecticides India BUY RESULTS REVIEW 4QFY17 30 MAY 2017

Radico Khaitan BUY RESULTS REVIEW 3QFY19 24 JAN 2019

Thangamayil BUY RESULTS REVIEW 2QFY19 15 NOV 2018

V-Guard BUY RESULTS REVIEW 3QFY19 02 FEB 2019

Hexaware Technologies

Emami NEUTRAL RESULTS REVIEW 4QFY15 14 MAY 2015

Real Estate. 4QFY17E Results Preview. 13 Apr Parikshit D Kandpal

Oil & Gas. 4QFY17E Results Preview. 13 Apr Deepak Kolhe

Lupin BUY COMPANY UPDATE 12 SEP 2013

Weak quarter but well placed

IRB Infrastructure Developers

Coal India. Tough times BUY COMPANY UPDATE 22 AUG CMP (as on 21 Aug 17) Rs 238 Target Price Rs 300

Mindtree. Steady quarter, Upside capped NEUTRAL RESULTS REVIEW 4QFY19 18 APR INDUSTRY CMP (as on 16 Apr 2019) Rs 972 Target Price Rs 1,040

Margin boost through non-core book

ITD Cementation (India) Ltd.

Outperformance continues

Chemicals and Fertilisers

Autos. 4QFY18E Results Preview. 12 Apr Abhishek Jain

Construction & Infra. 1QFY19E Results Preview 10 JUL Parikshit D Kandpal

FIRSTSOURCE SOLUTIONS LTD.

V-Guard. On track BUY COMPANY UPDATE 27 SEP 2017

Brigade Enterprises BUY RESULTS REVIEW 2QFY16 03 NOV Highlights of the quarter. CMP (as on 03 Nov 2015) Rs 162 Target Price Rs 210

IRB Infrastructure Developers

All eyes on acquired assets

Transcription:

INDUSTRY AUTOS CMP(as on 23 May 2018) Rs 158 Target Price Rs 217 Nifty 10,430 Sensex 34,345 KEY STOCK DATA Bloomberg NRBBR IN No. of Shares (mn) 97 MCap (Rs bn) / ($ mn) 15/224 6m avg traded value (Rs mn) 47 STOCK PERFORMANCE (%) 52 Week high / low Rs 183/107 3M 6M 12M Absolute (%) (1.8) 13.6 40.9 Relative (%) (2.4) 11.3 27.8 SHAREHOLDING PATTERN (%) Promoters 53.63 FIs & Local MFs 17.39 FPIs 16.06 Public & Others 12.92 Source : BSE Abhishek Jain abhishekkumar.jain@hdfcsec.com +91-22-6171-7314 Strong Show NRB posted strong numbers in 4QFY18. Revenue came in at Rs 2.35bn (+25% YoY), fuelled by strong growth across OEMs segments (2W, CV and tractor segment) and export. EBITDA rose 69% YoY to Rs 422mn with margin at 17.9% (+468bps YoY), driven by operating leverage and richer product mix (higher revenue from CVs). APAT at Rs. 268mn (+129% YoY, 26% QoQ) led by strong operating performance and higher other income (Fx gain Rs 50mn) NRB s growth story is premised on (1) Strong volume growth in OEMs (account for ~65% of revenue), (2) Revival in exports, led by a recovery in the North- American and European truck /PV markets (~22% of revenue), (3) Incremental revenue from the Defence, Aerospace and Railway segments, and (4) Reduction in debt along with fall in interest cost. We have increased our 19/20E by 20/18% factoring in revival in CV and export sales along with margin expansion. We value the stock at Rs 217(18xFY20E EPS). Maintain Buy RESULTS REVIEW 4QFY18 23 MAY 2018 NRB Bearings BUY Highlights of the quarter Strong growth in OEMs: Growth was visible across OEMs segments mainly CV and 2W segment. Although the replacement market remains muted. Product mix was favourable with higher share of CVs. The company is also looking to procure incremental revenue from the Defence, Marine and Railway segments. Improving exports: Revenue from exports picked up(~+20% YoY in FY18), driven by the combined impact of a pick-up in orders from the heavy truck segment in North America, growth in the European PV market, and appreciation of the Euro. Revenue from other geographies (ASEAN region and Iran) also supported export growth. Improvement in WC and Net debt: Improvement in working capital is visible (116 days in FY18 vs 134 days in end FY-17) and net debt has reduced to Rs 1.73bn in FY18 vs Rs 2.35bn in end-fy17. Near-term outlook: Expect strong earnings growth in 1Q, led by rising CV and 2W domestic volume along with pick-up in exports. Financial Summary (Rs mn) 4QFY18 4QFY17 YoY (%) 3QFY18 QoQ (%) FY17 FY18 FY19E FY20E Net Sales 2,353 1,880 25.2 2,078 13.2 7,255 8,551 9,517 10,615 EBITDA 422 249 69.4 405 4.2 1,167 1,683 1,841 2,054 APAT 268 117 129.3 212 26.3 517 907 1,021 1,169 Diluted EPS (Rs) 2.8 1.2 129.3 2.2 26.3 5.3 9.4 10.5 12.1 P/E (x) 30.0 17.1 15.2 13.3 EV / EBITDA (x) 15.3 10.2 8.8 7.6 RoE (%) 17.7 26.6 24.7 23.9 HDFC securities Institutional Research is also available on Bloomberg HSLB <GO>& Thomson Reuters

Top-line at Rs 2.35bn (+25%, ahead of its peers like SKF- 8% was led by strong growth in OEMs(specially CVs and 2W) and Export EBITDA margin expanded on the back of operating leverage, richer product mix, cost cutting initiatives and better export realization In 4QFY17, EBITDA margin was exceptionally low owing to GST related expenses Other income was higher owing to forex gain of Rs. 50mn Quarterly Financials Snapshot (Standalone) (Rs mn) 4QFY18 4QFY17 YoY (%) 3QFY18 QoQ (%) Net Sales (incl OOI) 2,353 1,880 25 2,078 13.2 Material Expenses 2,353 1,880 25 2,078 13.2 Employee Expenses 1,005 804 25 817 22.9 Other Operating Expenses 342 297 15 327 4.7 EBITDA 585 530 10 529 10.5 Depreciation 422 249 69 405 4.2 EBIT 73 74 (1) 59 24.4 Other Income 348 175 99 346 0.7 Interest Cost 77 16 378 8 843.9 PBT 34 38 (12) 34 (2.0) Tax 392 153 156 320 22.7 RPAT 124 36 241 108 15.5 APAT 268 117 129 212 26.3 Adj EPS 268 117 129 212 26.3 Margin Analysis 4QFY18 4QFY17 YoY (bps) 3QFY18 QoQ(bps ) Material Expenses As % Of Net Sales 42.7 42.7 (6) 39.3 336 Employee Expenses As % Of Net Sales 14.5 15.8 (127) 15.7 (119) Other Expenses As % Of Net Sales 24.9 28.2 (335) 25.5 (62) EBITDA Margin (%) 17.9 13.2 468 19.5 (156) Tax Rate (%) 31.7 23.8 792 33.6 (195) Net Profit Margin (%) 11.4 6.2 517 10.2 117 Change in Estimates In Rs mn New Old % chg FY19E FY20E FY19E FY20E FY19E FY20E Net Sales 9,517 10,615 9,170.3 10,238.4 3.8 3.7 EBITDA 1,841 2,054 1,633.7 1,844.5 12.7 11.3 Adj PAT 1,021 1,169 845.8 987.9 20.7 18.4 Adj EPS (in Rs) 10.5 12.1 8.7 10.2 20.7 18.4 Source: HDFC sec Inst Research Page 2

With 65% revenue coming in from domestic OEMs, NRB is expected to be a key beneficiary of robust growth in the Automobile sector 2Ws and CVs will remain top contributors to revenue growth Peer Valuations MCap (Rs bn) CMP (Rs/sh) Key Assumptions FY16 FY17 FY18E FY19E FY20E Domestic Revenue 5,379 5,759 6,654 7,393 8,236 Growth (%) 6.0% 7.1% 15.5% 11.1% 11.4% OEM 4,421 4,802 5,643 6,281 7,006 Growth (%) 5.5% 8.6% 17.5% 11.3% 11.5% Aftermarket 958 957 1,011 1,112 1,230 Growth (%) 8.2% -0.1% 5.6% 10.0% 10.7% Export 1,370 1,517 1,896 2,124 2,379 Growth (%) -15.8% 10.7% 25.0% 12.0% 12.0% Total Revenue 6,749 7,276 8,550 9,517 10,615 Growth (%) 0.7% 7.8% 17.5% 11.3% 11.5% Revenue Break Up(Domestic) 2W 30% 31% 32% 32% 32% PV 15% 15% 14% 14% 13% CV 28% 26% 28% 28% 28% Tractor & Farm Equip 10% 12% 12% 12% 12% Others 17% 15% 15% 15% 16% Source: HDFC sec Inst Research Rating TP Adj EPS (Rs/sh) P/E (x) EV/EBITDA (x) RoE (%) FY18 FY19E FY20E FY18 FY19E FY20E FY18 FY19E FY20E FY18 FY19E FY20E Exide Industries 214 252 BUY 298 8.4 11.1 13.0 30.2 22.8 19.3 18.3 16.9 12.9 14.9 13.9 16.7 Jamna Auto 37 93 NEU 90 3.0 3.8 4.8 30.8 24.2 19.4 18.1 14.3 11.5 32.5 33.3 33.5 Suprajit Engineering 36 278 NEU 296 10.3 14.0 16.6 27.0 19.8 16.8 16.2 12.4 10.7 24.6 26.5 25.0 Ramkrishna Forgings 21 741 BUY 913 19.6 34.9 51.3 37.9 21.3 14.4 12.1 9.1 6.8 10.5 14.7 18.7 Subros 18 296 BUY 384 9.1 13.4 19.2 32.5 22.1 15.4 18.8 15.4 12.8 14.8 19.1 23.3 JBM Auto 16 390 BUY 560 17.0 24.6 31.1 22.9 15.9 12.5 10.2 7.6 6.3 18.0 22.7 21.7 NRB Bearings 16 160 BUY 217 9.4 10.5 12.1 17.1 15.2 13.3 10.2 8.8 7.6 26.6 24.7 23.9 Lumax Autotech 11 825 BUY 987 36.3 43.8 54.9 22.7 18.8 15.0 10.3 8.4 6.5 14.7 15.8 17.4 Page 3

Net Revenue On The Rise Gross Margin Remained flat YoY Net Revenue (Rs mn) % YoY (RHS) Gross profit(rs. Mn) Gross margin (RHS) The company is the key beneficiary of resurgence in the CV volume, and resumption of a key export order The company is looking a capex of Rs. 650 in FY19 for expanding its capacity 2,500 2,000 1,500 1,000 500-4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% 1,600 1,400 1,200 1,000 800 600 400 200-4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 % 4QFY18 62.00 61.00 60.00 59.00 58.00 57.00 56.00 55.00 54.00 53.00 52.00 51.00 EBITDA Margin Improved On Richer Mix One-year Forward P/E Chart Current valuation at 15x; FY19E is below its historical mean (19x) 450 400 350 300 250 200 150 100 50-4QFY16 EBITDA (Rs mn) 1QFY17 2QFY17 3QFY17 4QFY17 EBITDA margin (RHS) % 1QFY18 2QFY18 3QFY18 4QFY18 25 20 15 10 5 - P/E (x) Mean +1 SD -1 SD 34.0 31.0 28.0 25.0 22.0 19.0 16.0 13.0 10.0 Oct-14 Jan-15 Apr-15 Jul-15 Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Page 4

Income Statement(Consolidated) (Rs mn) FY16 FY17 FY18 FY19E FY20E Net Revenues 6,749 7,255 8,551 9,517 10,615 Growth (%) 0.7% 7.5% 17.9% 11.3% 11.5% Material Expenses 2,621 2,720 3,287 3,726 4,156 Power & Fuel expenses 294 320 - - - Employee Expenses 1,284 1,316 1,449 1,618 1,805 Other Operating Expenses 1,438 1,732 2,132 2,332 2,601 EBITDA 1,112 1,167 1,683 1,841 2,054 EBITDA Margin (%) 16.5% 16.1% 19.7% 19.3% 19.3% EBITDA Growth (%) -10.3% 5.0% 44.1% 9.4% 11.5% Depreciation 319 323 310 325 344 EBIT 792 844 1,373 1,516 1,710 Other Income (Incl. EO Items) 32 80 122 85 90 Interest 185 170 142 93 74 PBT 639 753 1,353 1,508 1,726 Tax (Incl Deferred) 207 223 424 467 535 Minority Interest 12 14 22 20 22 APAT 420 517 907 1,021 1,169 APAT Growth (%) -19.6% 23.0% 75.5% 12.6% 14.6% Adj EPS 4.3 5.3 9.36 10.5 12.1 EPS Growth (%) -20% 23% 76% 13% 15% Balance Sheet (Consolidated) (Rs mn) FY16 FY17 FY18 FY19E FY20E SOURCES OF FUNDS Share Capital - Equity 194 194 194 194 194 Reserves 2,598 2,846 3,586 4,300 5,119 Total Shareholders Funds 2,792 3,040 3,779 4,494 5,313 Minority Interest 41 55 77 97 118 Long Term Debt 618 1,073 689 539 389 Short Term Debt 2,058 1,507 1,327 897 747 Total Debt 2,676 2,580 2,016 1,436 1,136 Net Deferred Taxes 117 36 58 58 58 Long Term Provisions & Others 129 7 0 - - TOTAL SOURCES OF FUNDS 5,755 5,717 5,930 6,084 6,624 APPLICATION OF FUNDS Net Block 2,595 2,470 2,596 2,671 2,727 CWIP 48 88 148 248 348 Investments - 61 144 - - LT Loans & Advances 640 660 938 763 781 Total Non-current Assets 3,283 3,278 3,826 3,682 3,855 Inventories 1,447 1,723 1,580 1,838 2,050 Debtors 2,259 1,937 2,334 2,347 2,617 Other Current Assets 37 70 75 77 79 Cash & Equivalents 320 225 288 766 931 Total Current Assets 4,064 3,954 4,278 5,028 5,678 Creditors 899 994 1,187 1,219 1,360 Other Current Liabilities &Provns 693 521 986 1,407 1,550 Total Current Liabilities 1,592 1,515 2,174 2,626 2,910 Net Current Assets 2,472 2,439 2,104 2,402 2,769 TOTAL APPLICATION OF FUNDS 5,755 5,717 5,930 6,084 6,624 Page 5

Cash Flow (Consolidated) (Rs mn) FY16 FY17 FY18 FY19E FY20E Reported PBT 639 753 1,353 1,508 1,726 Interest expenses 185 170 142 93 74 Depreciation 319 323 310 325 344 Working Capital Change 141 (366) 135 345 (229) Tax Paid (207) (223) (424) (467) (535) OPERATING CASH FLOW ( a ) 1,077 659 1,515 1,804 1,380 Capex (192) (326) (408) (500) (500) Free cash flow (FCF) 885 332 1,107 1,304 880 Investments - 61 83 (144) - INVESTING CASH FLOW ( b ) (192) (265) (325) (644) (500) Debt Issuance/(Repaid) (488) 208 (564) (300) (300) Interest Expenses (185) (170) (142) (93) (74) FCFE 212 370 401 911 507 Share Capital Issuance Others - - - - - Dividend (281) (165) (242) (306) (351) FINANCING CASH FLOW ( c ) (845) (489) (1,128) (681) (716) NET CASH FLOW (a+b+c) 40 (95) 62 479 165 Closing Cash & Equivalents 320 225 287 766 931 Key Ratios (Consolidated) FY16 FY17 FY18 FY19E FY20E PROFITABILITY (%) GPM 61.2 62.5 61.6 60.8 60.8 EBITDA Margin 16.5 16.1 19.7 19.3 19.3 APAT Margin 6.2 7.1 10.6 10.7 11.0 RoE 15.7 17.7 26.6 24.7 23.9 RoIC (or Core RoCE) 11.2 12.3 20.5 23.4 25.4 RoCE 9.5 11.1 17.2 18.1 19.2 EFFICIENCY Tax Rate (%) 32.4 29.6 31.3 31.0 31.0 Fixed Asset Turnover (x) 1.30 1.43 1.69 1.81 1.97 Inventory (days) 78.3 86.7 67.5 70.5 70.5 Debtors (days) 122.2 97.4 99.6 90.0 90.0 Other Current Assets (days) 2.0 3.5 3.2 3.0 2.7 Payables (days) 48.6 50.0 50.7 46.7 46.7 Other Current Liab & Provns (days) 37.5 26.2 42.1 54.0 53.3 Cash Conversion Cycle (days) 116.4 111.4 77.5 62.7 63.2 Debt/EBITDA (x) 2.4 2.2 1.2 0.8 0.6 Net D/E (x) 0.8 0.8 0.5 0.1 0.0 Interest Coverage (x) 4.3 5.0 9.7 16.2 23.2 PER SHARE DATA (Rs) EPS 4.3 5.3 9.4 10.5 12.1 CEPS 7.6 8.7 12.6 13.9 15.6 Dividend 2.9 1.6 2.6 3.2 3.6 Book Value 28.8 31.4 39.0 46.4 54.8 VALUATION P/E (x) 36.9 30.0 17.1 15.2 13.3 P/BV (x) 5.6 5.1 4.1 3.5 2.9 EV/EBITDA (x) 16.1 15.3 10.2 8.8 7.6 EV/Revenues (x) 2.6 2.5 2.0 1.7 1.5 OCF/EV (%) 6.0 3.7 8.8 11.2 8.8 FCF/EV (%) 5.0 1.9 6.4 8.1 5.6 FCFE/Mkt Cap (%) 1.4 2.4 2.6 5.9 3.3 Dividend Yield (%) 1.8 1.0 1.6 2.0 2.3 Page 6

RECOMMENDATION HISTORY RECOMMENDATION HISTORY NRB 220 200 180 160 140 120 TP Date CMP Reco Target 24-May-17 112 BUY 161 31-May-17 118 BUY 161 14-Aug-17 112 BUY 161 11-Oct-17 128 BUY 161 7-Nov-17 143 BUY 172 9-Jan-18 171 BUY 192 15-Feb-18 166 BUY 204 12-Apr-18 161 BUY 204 23-May-18 158 BUY 217 Rating Definitions 100 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 BUY : Where the stock is expected to deliver more than 10% returns over the next 12 month period NEUTRAL : Where the stock is expected to deliver (-)10% to 10% returns over the next 12 month period SELL : Where the stock is expected to deliver less than (-)10% returns over the next 12 month period Page 7

Disclosure: I, Abhishek Jain, MBA, author and the name subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest. Any holding in stock No HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475. Disclaimer: This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published for any purposes without prior written approval of HSL. Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments. HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business. HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report. HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Compliance Officer: Binkle R. Oza Email: complianceofficer@hdfcsec.com Phone: (022) 3045 3600 HDFC Securities Limited, SEBI Reg. No.: NSE-INB/F/E 231109431, BSE-INB/F 011109437, AMFI Reg. No. ARN: 13549, PFRDA Reg. No. POP: 04102015, IRDA Corporate Agent License No.: HDF 2806925/HDF C000222657, SEBI Research Analyst Reg. No.: INH000002475, CIN - U67120MH2000PLC152193 Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing. Page 8

HDFC securities Institutional Equities Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park, Senapati Bapat Marg, Lower Parel,Mumbai - 400 013 Board : +91-22-6171 7330www.hdfcsec.com Page 9